MERCK & CO., INC. (MRK)
Clinical trial NCT04074096 updates: 1. completion date: 2026-03-27 → 2027-03-27 2. primary completion date: 2026-03-27 → 2026-05-07
Clinical trial NCT04074096 updates: 1. completion date: 2026-03-27 → 2027-03-27 2. primary completion date: 2026-03-27 → 2026-05-07
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical